These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28624200)

  • 1. Mathematical Modeling: A Tool for Optimization of Lipid Nanoparticle-Mediated Delivery of siRNA.
    Mihaila R; Ruhela D; Keough E; Cherkaev E; Chang S; Galinski B; Bartz R; Brown D; Howell B; Cunningham JJ
    Mol Ther Nucleic Acids; 2017 Jun; 7():246-255. PubMed ID: 28624200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Kinetics of Lipid-Nanoparticle- Mediated Delivery of Multiple siRNAs to Evaluate the Effect on Competition for Ago2.
    Mihaila R; Ruhela D; Galinski B; Card A; Cancilla M; Shadel T; Kang J; Tep S; Wei J; Haas RM; Caldwell J; Flanagan WM; Kuklin N; Cherkaev E; Ason B
    Mol Ther Nucleic Acids; 2019 Jun; 16():367-377. PubMed ID: 30991218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery.
    Gindy ME; DiFelice K; Kumar V; Prud'homme RK; Celano R; Haas RM; Smith JS; Boardman D
    Langmuir; 2014 Apr; 30(16):4613-22. PubMed ID: 24684657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus.
    Sato Y; Matsui H; Yamamoto N; Sato R; Munakata T; Kohara M; Harashima H
    J Control Release; 2017 Nov; 266():216-225. PubMed ID: 28986168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene knockdown in HaCaT cells by small interfering RNAs entrapped in grapefruit-derived extracellular vesicles using a microfluidic device.
    Itakura S; Shohji A; Amagai S; Kitamura M; Takayama K; Sugibayashi K; Todo H
    Sci Rep; 2023 Feb; 13(1):3102. PubMed ID: 36813850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
    Zhang J; Haas RM; Leone AM
    Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic hydrodynamic focusing synthesis of polymer-lipid nanoparticles for siRNA delivery.
    Huang X; Lee RJ; Qi Y; Li Y; Lu J; Meng Q; Teng L; Xie J
    Oncotarget; 2017 Nov; 8(57):96826-96836. PubMed ID: 29228574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery.
    Kimura N; Maeki M; Sato Y; Note Y; Ishida A; Tani H; Harashima H; Tokeshi M
    ACS Omega; 2018 May; 3(5):5044-5051. PubMed ID: 31458718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
    Sato Y; Matsui H; Sato R; Harashima H
    J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
    Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
    Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-step microfluidic synthesis of transferrin-conjugated lipid nanoparticles for siRNA delivery.
    Li Y; Lee RJ; Huang X; Li Y; Lv B; Wang T; Qi Y; Hao F; Lu J; Meng Q; Teng L; Zhou Y; Xie J; Teng L
    Nanomedicine; 2017 Feb; 13(2):371-381. PubMed ID: 27720989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
    Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
    Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kawase W; Kurotaki D; Suzuki Y; Ishihara H; Ban T; Sato GR; Ichikawa J; Yanai H; Taniguchi T; Tsukahara K; Tamura T
    Mol Ther Nucleic Acids; 2021 Sep; 25():708-715. PubMed ID: 34589288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based nanoparticle formulations for small molecules and RNA drugs.
    Ickenstein LM; Garidel P
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1205-1226. PubMed ID: 31530041
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm.
    Wang W; Feng S; Ye Z; Gao H; Lin J; Ouyang D
    Acta Pharm Sin B; 2022 Jun; 12(6):2950-2962. PubMed ID: 35755271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of an in vitro assay to screen lipid based nanoparticles for siRNA delivery.
    Zhang Y; Arrington L; Boardman D; Davis J; Xu Y; DiFelice K; Stirdivant S; Wang W; Budzik B; Bawiec J; Deng J; Beutner G; Seifried D; Stanton M; Gindy M; Leone A
    J Control Release; 2014 Jan; 174():7-14. PubMed ID: 24240015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.